文献速递肿瘤 PET/CT

非小细胞肺癌的多功能评估:灌注-代谢相关性研究

Multifunctional Assessment of Non-Small Cell Lung Cancer: Perfusion-Metabolic Correlation.
PubMed 文献 · Clin Nucl Med · 2018-01-01

本研究前瞻性纳入25例非小细胞肺癌患者,探讨全肿瘤CT灌注参数与FDG PET/CT参数之间的关系。结果显示灌注与代谢参数似乎依赖于肿瘤大小:肿瘤越大,血流量和血容量越低,而SUVpeak、代谢肿瘤体积和总病灶糖酵解越高。作者认为该信息对非小细胞肺癌的诊断或治疗有临床价值,尤其涉及新型治疗和/或放疗调制时。

要点

  • 肿瘤直径和体积与血流量、血容量呈负相关,与平均通过时间呈正相关。
  • SUVmax、SUVpeak、SUVmean与病灶体积呈正相关,在≤3 cm病灶中相关更明显。
  • 代谢肿瘤体积和总病灶糖酵解与病灶直径和体积呈正相关,总体及>3 cm亚组均如此。

核心结论

  • 灌注和代谢参数似乎依赖于肿瘤大小;肿瘤越大,血流量和血容量越低,而SUVpeak、代谢肿瘤体积和总病灶糖酵解越高。
  • 作者认为该信息在非小细胞肺癌的诊断或治疗中有临床价值,尤其涉及新型治疗和/或放疗调制时。

研究设计与样本

  • 前瞻性纳入25例非小细胞肺癌患者,计算全肿瘤CT灌注参数(血流量、血容量、平均通过时间、峰值强化强度)并与FDG PET/CT参数(SUVmax、SUVpeak、SUVmean、代谢肿瘤体积、总病灶糖酵解)进行相关性分析。
  • 测量肿瘤直径和体积,并按最大轴径>3 cm和≤3 cm将病灶分组,在所有肿瘤中以及按肿瘤直径和体积分组评估CT灌注与PET/CT参数间的相关性。

主要发现

  • 病灶直径和体积与血流量及血容量的相关系数分别为r=-0.78、-0.78、-0.57、-0.48,与平均通过时间的相关系数分别为r=0.55、0.65。
  • 在>3 cm病灶亚组中,血流量与病灶直径和体积的负相关得到证实,r均为-0.68。
  • SUVmax、SUVpeak、SUVmean与病灶体积呈正相关,r分别为0.50、0.50、0.46,并在≤3 cm病灶中证实,r分别为0.81、0.79、0.78。
  • 代谢肿瘤体积和总病灶糖酵解与病灶直径和体积在总体人群中呈正相关,r分别为0.93、0.87、0.88、0.90,在>3 cm病灶中r分别为0.89、0.84、0.84、0.79。
  • 血流量和血容量与代谢肿瘤体积及总病灶糖酵解在总体人群中呈负相关,r分别为-0.77、-0.74和-0.58、-0.48;在>3 cm病灶中与代谢肿瘤体积呈负相关,r分别为-0.69、-0.62。

临床怎么用

  • 作者认为该信息在非小细胞肺癌的诊断或治疗中有临床价值,尤其涉及新型治疗和/或放疗调制时。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of this study was to investigate the relationship between whole-tumor CT perfusion and FDG PET/CT parameters in non-small cell lung cancer (NSCLC). METHODS: Twenty-five patients with NSCLC were prospectively included. CT perfusion parameters calculated were blood flow (BF), blood volume (BV), mean transit time, and peak enhancement intensity. SUVmax, SUVpeak, SUVmean, metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were evaluated for PET/CT. Tumor diameter and volume were measured, and lesions were divided according to maximum axial diameter in more than 3 cm and 3 cm or less. The correlations between CT perfusion and PET/CT parameters were assessed in all tumors, as well as according to tumor diameter and volume. RESULTS: Lesion diameter and volume showed a negative correlation with BF and BV (r = -0.78, -0.78, -0.57, -0.48, respectively) and a positive correlation with mean transit time (r = 0.55, 0.65, respectively). The negative correlation between BF and lesion diameter and volume was confirmed in the subgroup of lesions of more than 3 cm (r = -0.68, -0.68, respectively). A positive correlation between SUVmax, SUVpeak, SUVmean, and lesion volume was observed (r = 0.50, 0.50, 0.46, respectively) and confirmed in lesions 3 cm or less (r = 0.81, 0.79, 0.78, respectively). Metabolic tumor volume and TLG showed a positive correlation with lesion diameter and volume in the overall population (r = 0.93, 0.87, 0.88, 0.90, respectively) and in lesions of more than 3 cm (r = 0.89, 0.84, 0.84, 0.79, respectively). Blood flow and BV showed a negative correlation with MTV and TLG (r = -0.77, -0.74, and -0.58, -0.48, respectively) in the overall population and with MTV in lesions of more than 3 cm (r = -0.69, -0.62, respectively). CONCLUSIONS: Perfusion and metabolic parameters seem to depend on tumor size. The bigger the tumor, the lower the BF and the BV and, conversely, the higher the SUVpeak, MTV, and TLG. This information would be useful in the clinical setting when diagnosing or treating NSCLC, especially with novel therapies and/or for radiation treatment modulation.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Calandriello L, Larici AR, Leccisotti L, et al. Multifunctional Assessment of Non-Small Cell Lung Cancer: Perfusion-Metabolic Correlation. Clin Nucl Med. 2018. PMID: 29189372. doi:10.1097/RLU.0000000000001888

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。